Dr. Daniel Lyndon Rowady, MD

Dr. Rowady practices at Rowady Primary Physician Practice in Pasadena, California.

Dr. Rowady's NPI, 1578661609, was assigned on September 20, 2006. Dr. Rowady graduated from Wayne State University School Of Medicine in 1999. Dr. Rowady holds California license A73692.

Dr. Rowady's primary practice is Rowady Primary Physician Practice, at 630 S Raymond Ave Unit 240, Pasadena, CA 91105-3283. The practice phone is (626) 345-6880.

Dr. Rowady's primary practice is Rowady Primary Physician Practice in Pasadena, California. Dr. Rowady is also affiliated with Huntington Hospital. The medical group on file is Pachorek MD INC, Joseph J. Dmand AI also links Dr. Rowady to 1 more hospital, 2 home health agencies, 2 skilled nursing facilities and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rowady practices, 8 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Rowady's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Rowady is licensed in California.

Dmand AI lists acid reflux, acute kidney failure, acute skin infection, ADHD, adjustment disease, alcohol use disorders, alzheimer's disease and anxiety among the conditions Dr. Rowady treats.

CMS data shows 1,561 Medicare services from Dr. Rowady across 9 procedure codes in 2024, for 466 Medicare patients. Medicare paid $171,744 for them. Every service was in an office.

CMS counts 466 Medicare patients who saw Dr. Rowady in 2024. The largest group is 75 to 84, with 198 patients. 66% of them have high cholesterol, and 63% have high blood pressure. 6% are also on Medicaid. Their average risk score is 1.02, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Rowady's median patient age at 69, with 36% women.

In 2024, Dr. Rowady wrote 9,305 Medicare Part D claims for 643 patients. 87% of them were for generic drugs. CMS names the drug for 8,459 of them, across 145 drugs with 11 or more claims each, at $752,346 in total drug cost. In 2023, CMS named 8,992 claims across 151 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Rowady for performance year 2024, reported individually. Dr. Rowady accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 98 general payments to Dr. Rowady from 21 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Abbott Laboratories paid the most, $1,162.

Dmand AI lists 1 award for Dr. Rowady, most recently CMS Stage 1 EHR in 2013.

Dr. Rowady graduated from Wayne State University School Of Medicine in 1999.

Dr. Rowady is in network with 17 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.